Assignee
CELYAD ONCOLOGY S A
BE·0 granted patents·4 pending applications·0 citations·filing 2020–2022
Top patents by PatentIndex Score
4 records- 0138US2025263715A1Improved chimeric and engineered scaffolds and clusters of multiplexed inhibitory rnaCELYAD ONCOLOGY S A·Filed 2022·Application pending·0 cites
- 0237US2024366668A1Nkg2d car cells expressing il-18 for adoptive cell therapyCELYAD ONCOLOGY S A·Filed 2022·Application pending·0 cites
- 0334US2023159928A1Improved scaffolds for multiplexed inhibitory rnaCELYAD ONCOLOGY S A·Filed 2021·Application pending·0 cites
- 0433US2022313737A1Cd52-deficient cells for adoptive cell therapyCELYAD ONCOLOGY S A·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CELYAD ONCOLOGY S A files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →